Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Congratulations to Professor Gero Miesenböck (Department of Physiology, Anatomy and Genetics) who is to be awarded the 2022 Louisa Gross Horwitz Prize, together with Professors Karl Deisseroth and Peter Hegemann, for research that laid the foundation for the field of optogenetics.

Gero Miesenböck

Professor Gero Miesenböck, Department of Physiology, Anatomy and Genetics (DPAG) Waynflete Professor of Physiology and Director of the Centre for Neural Circuits and Behaviour, is one of three scientists to be awarded the 2022 Louisa Gross Horwitz Prize for pioneering work in the field of optogenetics.

Optogenetics uses light and genetic modification to control the activity of cells in the brain, allowing researchers to precision-target neurons in the brain and study how the activity of these cells contributes to simple and complex behaviours. The technique has revolutionised the study of the nervous system, having helped scientists to better understand how brain circuitry controls a wide range of behaviours including learning, sleep, vision, movement and addiction. It has increased the potential for treating diseases such as epilepsy, spinal injury, multiple sclerosis, and Parkinson’s. 

Read the full story on the DPAG website

 

 

 

 

Similar stories

Exceptional early-career researchers awarded 2026 European Research Council Starting Grants

Four University of Oxford researchers have been awarded prestigious European Research Council (ERC) Starting Grants, each worth €1.5 million for a period of up to five year

How body fat is stored across organs may reveal hidden health risks, study suggests

Researchers from the Nuffield Department of Population Health and the University of Oxford’s Big Data Institute have contributed to a new study showing that how fat accumulates in the body is just as important for identifying different health risks as a person’s overall weight.

Four Oxford researchers recognised in the 2026 Royal Society Awards

The annual Royal Society Awards recognise outstanding contributions to scientific discovery, public engagement and research culture. Of the 27 awards for 2025-26, announced today, four honour Oxford University researchers.

New shingles vaccine linked to lower risk of coronary heart disease, stroke and heart failure – major study indicates

The shingles vaccine currently in use, called ‘Shingrix’, is associated with a reduced risk of cardiovascular events – including heart attacks, heart failure and stroke – compared to the previous shingles vaccine, according to a major new study published in Nature Medicine.

Vapes help more people quit smoking than other methods, Oxford-led Cochrane review finds

An updated Cochrane review led by Oxford researchers finds nicotine e-cigarettes help more people quit smoking than nicotine patches and gum, behavioural support or no support. The living review now includes 80 trials and nearly 30,000 participants.

Brain imaging study reveals how we decide whether we are in control

A brain imaging and stimulation study led by the University of Oxford has identified the brain mechanisms that help us work out whether the consequences we experience are caused by our own actions or by circumstances beyond our control.